Physician profile
Robert W Kopp
NPI 1487913794
$2,165.50
in general payments reported to CMS, 2019-2025
10 companies · $620 in 2025
The $620 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $84.01 · 2021: $214 · 2022: $348 · 2023: $449 · 2024: $218 · 2025: $620.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,255 · Education: $32.10.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,254.56 |
| Education | $32.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,331.15 | 2019-2025 | Scopis Ent, Fiagon Navigation Unit, Xpress Loprofile |
| Medtronic, INC. | $423.68 | 2023-2025 | Propel, Stealthstation S8 Platform |
| Regeneron Healthcare Solutions, INC. | $126.50 | 2025 | Dupixent |
| Genzyme Corporation | $111.54 | 2019-2025 | |
| Aerin Medical INC. | $59.76 | 2023-2025 | |
| Glaxosmithkline, LLC. | $31.86 | 2023 | Nucala |
| Alk-Abello, INC | $27.68 | 2019 | |
| Paratek Pharmaceuticals, INC. | $21.05 | 2025 | Xhance |
| Medtronic USA, INC. | $19.66 | 2020 | |
| Kaleo, INC. | $12.62 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kopp listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.